Literature DB >> 18322295

Primary ovarian insufficiency associated with imatinib therapy.

Constantinos Christopoulos, Vasiliki Dimakopoulou, Evangelos Rotas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18322295     DOI: 10.1056/NEJMc0707841

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  20 in total

1.  Will imatinib compromise reproductive capacity?

Authors:  Alberuni M Zamah; Michael J Mauro; Brian J Druker; Kutluk Oktay; Merrill J Egorin; Marcelle I Cedars; Mitchell P Rosen
Journal:  Oncologist       Date:  2011-09-23

2.  Pediatric chronic myeloid leukemia is a unique disease that requires a different approach.

Authors:  Nobuko Hijiya; Kirk R Schultz; Markus Metzler; Frederic Millot; Meinolf Suttorp
Journal:  Blood       Date:  2015-10-28       Impact factor: 22.113

3.  Planned Pregnancy in Female Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy.

Authors:  Xuelin Dou; Yazhen Qin; Xiaojun Huang; Qian Jiang
Journal:  Oncologist       Date:  2019-06-11

Review 4.  Endocrine side effects of broad-acting kinase inhibitors.

Authors:  Maya B Lodish; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2010-08-16       Impact factor: 5.678

Review 5.  Clinical review: kinase inhibitors: adverse effects related to the endocrine system.

Authors:  Maya B Lodish
Journal:  J Clin Endocrinol Metab       Date:  2013-02-28       Impact factor: 5.958

6.  More about masitinib.

Authors:  Ulrich A Walker
Journal:  Arthritis Res Ther       Date:  2009-07-13       Impact factor: 5.156

7.  Long-term imatinib diminishes ovarian reserve and impacts embryo quality.

Authors:  Wael Salem; Jacqueline R Ho; Irene Woo; Sue A Ingles; Karine Chung; Richard J Paulson; Lynda K McGinnis
Journal:  J Assist Reprod Genet       Date:  2020-05-06       Impact factor: 3.412

Review 8.  Premature ovarian insufficiency: pathogenesis and therapeutic potential of mesenchymal stem cell.

Authors:  Akimasa Takahashi; Abdelrahman Yousif; Linda Hong; IIana Chefetz
Journal:  J Mol Med (Berl)       Date:  2021-02-27       Impact factor: 4.599

Review 9.  Fertility considerations in targeted biologic therapy with tyrosine kinase inhibitors: a review.

Authors:  Anupama Rambhatla; Michael R Strug; Jessica Garcia De Paredes; Marcos I Cordoba Munoz; Mili Thakur
Journal:  J Assist Reprod Genet       Date:  2021-04-07       Impact factor: 3.357

10.  Successful ovarian stimulation and pregnancy in an infertile woman with chronic myeloid leukemia.

Authors:  Silvina J Rios; Lorena Martínez-Montesinos; Cristina Aroca; Raul Teruel-Montoya; Francisca Ferrer-Marín
Journal:  J Assist Reprod Genet       Date:  2020-08-06       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.